Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 15650076)

Published in Endocrinology on January 13, 2005

Authors

Tadashi Morimura1, Katsuhiko Tsunekawa, Takayuki Kasahara, Koji Seki, Takayuki Ogiwara, Masatomo Mori, Masami Murakami

Author Affiliations

1: Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan.

Articles citing this

Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts. Proc Natl Acad Sci U S A (2010) 1.03

The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid (2010) 1.00

Iodothyronine deiodinase enzyme activities in bone. Bone (2008) 0.91

Metabolic and clinical consequences of hyperthyroidism on bone density. Int J Endocrinol (2013) 0.87

Thyroid hormone deiodinases and cancer. Front Endocrinol (Lausanne) (2012) 0.83

Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease? Nutr Metab (Lond) (2010) 0.81

Homeostatic Control of the Thyroid-Pituitary Axis: Perspectives for Diagnosis and Treatment. Front Endocrinol (Lausanne) (2015) 0.80

Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease. Osteoporos Int (2006) 0.79

Thyroid-stimulating hormone is significantly associated with bone health status in men. Int J Med Sci (2013) 0.79

Thyroid function and bone mineral density among Indian subjects. Indian J Endocrinol Metab (2012) 0.79

Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma. Mol Cell Endocrinol (2008) 0.77

Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease. Thyroid Res (2013) 0.76

A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels. PLoS One (2015) 0.75

Type 2 Iodothyronine Deiodinase Activity Is Required for Rapid Stimulation of PI3K by Thyroxine in Human Umbilical Vein Endothelial Cells. Endocrinology (2015) 0.75

The Glu727 Allele of Thyroid Stimulating Hormone Receptor Gene is Associated with Osteoporosis. N Am J Med Sci (2012) 0.75

Lessons from the Bone Chapter of the Malaysian Aging Men Study. Int J Environ Res Public Health (2016) 0.75

Expanding the Role of Thyroid-Stimulating Hormone in Skeletal Physiology. Front Endocrinol (Lausanne) (2017) 0.75

Articles by these authors

Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature (2006) 3.19

Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol (2004) 2.88

Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid (2012) 2.78

Endoscopic treatment of rectal carcinoid tumors. Dis Colon Rectum (2010) 2.01

Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology (2007) 1.82

Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. Mol Cancer Ther (2011) 1.74

Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Ophthalmology (2004) 1.74

Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab (2009) 1.66

Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity. Metabolism (2008) 1.56

Functional gastrointestinal disorders in adolescents and quality of school life. J Gastroenterol Hepatol (2013) 1.50

Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen, and lipids in healthy subjects. Clin Hemorheol Microcirc (2006) 1.48

Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Methods (2007) 1.48

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy. Lung Cancer (2007) 1.48

Fulminant hepatic failure resulting from small-cell lung cancer and dramatic response of chemotherapy. World J Gastroenterol (2006) 1.45

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol (2003) 1.41

Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest (2007) 1.41

Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules. Circ J (2014) 1.39

Usefulness of cholescintigraphy with lipid meal loading for diagnosis and determination of cholecystectomy in a patient with gallbladder dysfunction. Intern Med (2004) 1.39

Vitreous collagen metabolism before and after vitrectomy. Graefes Arch Clin Exp Ophthalmol (2005) 1.39

Effect of exercise on circulating adipokine levels in obese young women. Endocr J (2006) 1.37

l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci (2008) 1.37

Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem (2006) 1.37

Primary amenorrhea accompanied by adrenal adenoma: start of menarche soon after tumor resection. Intern Med (2002) 1.37

Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun (2008) 1.33

Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun (2002) 1.32

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci (2007) 1.31

Stricture after endoscopic submucosal dissection for early gastric cancers and adenomas. Dig Endosc (2010) 1.28

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Clin Cancer Res (2005) 1.27

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells. BMC Cancer (2009) 1.25

Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology (2004) 1.24

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer. Lung Cancer (2007) 1.23

Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol (2006) 1.23

Barium sulphate aspiration. Lancet (2004) 1.21

Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res (2010) 1.20

Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis: case report and literature review. World J Gastroenterol (2006) 1.20

Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab (2012) 1.17

Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol (2006) 1.16

Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure. Intern Med (2010) 1.14

Endoscopic management of duodenal diverticular bleeding. Gastrointest Endosc (2007) 1.14

Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. J Cell Biol (2005) 1.11

A new anorexigenic protein, nesfatin-1. Peptides (2009) 1.09

C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol (2003) 1.09

Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) (2010) 1.08

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Int J Cancer (2011) 1.08

Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells. Diabetes (2008) 1.08

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene (2002) 1.07

Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res (2007) 1.07

CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Ann Surg Oncol (2009) 1.07

Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene (2002) 1.06

Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet β-cells. Endocr J (2011) 1.05

Primary liver cancers with nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol (2007) 1.05

Presence of Pseudomonas putida strains harboring plasmids bearing the metallo-beta-lactamase gene bla(IMP) in a hospital in Japan. J Clin Microbiol (2003) 1.05

A case of amebic liver abscess complicated by hemobilia due to rupture of hepatic artery aneurysm. Hepatogastroenterology (2002) 1.04

The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol (2007) 1.04

Clinical characteristics and treatment for patients presenting with bleeding duodenal varices. Dig Endosc (2010) 1.04

Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol (2007) 1.04

Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells. J Biol Chem (2009) 1.04

Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology (2006) 1.03

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer. Lung Cancer (2009) 1.02

Cytokines and STATs in Liver Fibrosis. Front Physiol (2012) 1.02

Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4. Immunol Lett (2002) 1.02

Primary mediastinal synovial sarcoma: a report of 2 cases. J Comput Assist Tomogr (2008) 1.01

Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab (2011) 1.01

c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogen-activated protein kinase in glutathione redox regulation of IL-12 production. J Immunol (2003) 1.01

Analysis of colonoscopic perforations at a local clinic and a tertiary hospital. World J Gastroenterol (2012) 1.01

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study. BMC Infect Dis (2009) 1.01

Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis. Clin Nucl Med (2007) 1.01

Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci (2003) 1.01

Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem (2005) 1.00

Nesfatin-1: an overview and future clinical application. Endocr J (2009) 1.00

Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun (2009) 1.00

Tyrosine phosphorylation of Munc18c regulates platelet-derived growth factor-stimulated glucose transporter 4 translocation in 3T3L1 adipocytes. Endocrinology (2007) 1.00

Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) (2010) 1.00

Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. J Biol Chem (2002) 0.99

Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci (2007) 0.99

Forearm muscle metastasis as an initial clinical manifestation of lung cancer. South Med J (2009) 0.99

CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation. J Biol Chem (2008) 0.99

Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int (2006) 0.98

The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis. Gut (2006) 0.98

Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep (2006) 0.98

Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer. Lung Cancer (2004) 0.98

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci (2009) 0.98

Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem (2005) 0.97

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer (2013) 0.97

Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol (2005) 0.97

Liver X receptor-alpha gene expression is positively regulated by thyroid hormone. Endocrinology (2007) 0.97

Chop-deficient mice showed increased adiposity but no glucose intolerance. Obesity (Silver Spring) (2007) 0.97

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology (2009) 0.96

Rapid gastric emptying, rather than delayed gastric emptying, might provoke functional dyspepsia. J Gastroenterol Hepatol (2011) 0.96

Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun (2010) 0.96

Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. J Cell Physiol (2010) 0.96

Monosodium L-glutamate added to a high-energy, high-protein liquid diet promotes gastric emptying. Am J Clin Nutr (2008) 0.95

Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone. Endocrinology (2009) 0.95

Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer? Int J Clin Oncol (2007) 0.95

Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal (2005) 0.95

Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. Endocrinology (2005) 0.95

Syntaxin 4 and Synip (syntaxin 4 interacting protein) regulate insulin secretion in the pancreatic beta HC-9 cell. J Biol Chem (2003) 0.95

Extracellular acidification stimulates IL-6 production and Ca(2+) mobilization through proton-sensing OGR1 receptors in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2010) 0.95

The role of CHOP messenger RNA expression in the link between oxidative stress and apoptosis. Metabolism (2008) 0.94